Apaxen raises €3.3 million in Series A Financing to Develop Breakthrough Anti-inflammatory Therapeutics for Pulmonary Arterial Hypertension (PAH) 11/09/201911/11/2020 by devin Press releasesLeave a Comment on Apaxen raises €3.3 million in Series A Financing to Develop Breakthrough Anti-inflammatory Therapeutics for Pulmonary Arterial Hypertension (PAH) Download the press release Télécharger le communiqué